The Role of Capsular Tension Ring (CTR) in Anterior Capsular Contraction

NCT ID: NCT00717080

Last Updated: 2012-01-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-07-31

Study Completion Date

2010-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a Randomized Controlled Trial to study the role of Capsular Tension Ring in patients with Retinitis Pigmentosa

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cataract is a common complication in retinitis Pigmentosa (RP) patient especially posterior sub capsular cataract. Continuous curvilinear capsulorhexis is the preferred method of capsulotomy in cataract surgery. Anterior capsular contraction (ACO) is a unique complication following cataract surgery. The rate of which is higher in RP patients due to the weak zonules and the increased rate of inflammation. CTR has been proven to reduce the rate of contraction.

Study population includes 40 eyes having RP with cataract. 20 eyes will receive CTR and the other 20 would not receive CTR. The percentage of anterior capsular contraction would be evaluated using EPCO software.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Retinitis Pigmentosa Cataract

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm 1

IOL surgery with Capsular Tension Ring

Group Type EXPERIMENTAL

IOL surgery

Intervention Type PROCEDURE

IOL surgery using capsular tension ring (AURORING)

Arm 2

IOL surgery without Capsular Tension Ring

Group Type PLACEBO_COMPARATOR

IOL surgery

Intervention Type PROCEDURE

IOL surgery without CTR

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

IOL surgery

IOL surgery using capsular tension ring (AURORING)

Intervention Type PROCEDURE

IOL surgery

IOL surgery without CTR

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

AURORING Phacoemulsification

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 35 to 65 years
* Typical retinitis pigmentosa
* Reside within a radius of 100kms from Madurai
* Patients willing to come for follow up
* Patients with nuclear sclerosis grade 2 or 3 or cortical cataract or pscc

Exclusion Criteria

* Diabetic patients
* Traumatic cataract
* Uveitis
* Glaucoma
* Pseudoexfoliation
* Myotonic dystrophy
* Corneal pathology
* Pupil size \<6mm
* Intra op complications like zonular dialysis,pc rupture
* Rhexis not covering iol optic
Minimum Eligible Age

35 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Aurolab

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Haripriya Aravind, MS

Role: PRINCIPAL_INVESTIGATOR

Aravind Eye Hospital, Madurai

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Aravind Eye Hospital

Madurai, Tamil Nadu, India

Site Status

Countries

Review the countries where the study has at least one active or historical site.

India

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2PR1210826

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.